Altamira Therapeutics Ltd. Description Of Risk Free Interest Rate Share Options Granted
Altamira Therapeutics Ltd. (CYTOF) reported Description Of Risk Free Interest Rate Share Options Granted of 3.62% for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted · last filed 2025-08-29
| Period end | Description Of Risk Free Interest Rate Share Options Granted | Description Of Risk Free Interest Rate Share Options Granted 6 month | Description Of Risk Free Interest Rate Share Options Granted 12 month |
|---|---|---|---|
| 2025-06-30 | 3.62% 6-K · filed 2025-08-29 | ||
| 2024-12-31 | 3.62% 20-F · filed 2025-04-30 | ||
| 2024-06-30 | 4.25% 6-K · filed 2024-09-24 | ||
| 2023-12-31 | 4.25% 6-K · filed 2025-08-29 | ||
| 2023-12-15 | 4.70% 20-F · filed 2025-04-30 |